| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.9K | $22.53M | - | |
| Other | 138.6K | $7.21M | - | |
| Other | 123.1K | $6.41M | - | |
| CFO | 116.9K | $6.08M | - | |
| Other | 111.5K | $5.80M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2022 | Calvin Sandra60 | VP, Corp Controller And CAO | Sell | 798 | $26.51 | $21,151.71 | -2.1% | -6.4% | -18.5% | |
| Jan 24, 2022 | Calvin Sandra60 | VP, Corp Controller And CAO | Sell | 934 | $24.58 | $22,954.64 | -3.2% | +9.9% | -16.2% | |
| Jan 24, 2022 | Clague Laura64 | Chief Financial Officer | Sell | 2,063 | $24.98 | $51,533.74 | -6.6% | +9.9% | -16.2% | |
| Jan 24, 2022 | Dube Eric M57 | Chief Executive Officer | Sell | 7,873 | $24.98 | $196,667.54 | -5.6% | +9.9% | -16.2% | |
| Jan 24, 2022 | Rote William E.58 | Senior Vice President, R&D | Sell | 1,875 | $24.98 | $46,837.50 | -4.9% | +9.9% | -16.2% | |
| Jan 24, 2022 | Heerma Peter53 | Chief Commercial Officer | Sell | 1,875 | $24.98 | $46,837.50 | -3.1% | +9.9% | -16.2% | |
| Jan 24, 2022 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 2,250 | $24.98 | $56,205.00 | -6.0% | +9.9% | -16.2% | |
| Jan 11, 2022 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 5,000 | $27.40 | $137,000.00 | -11.8% | +3.2% | -25.6% | |
| Jan 11, 2022 | Rote William E.58 | Senior Vice President, R&D | Sell | 2,500 | $27.40 | $68,500.00 | -6.1% | +3.2% | -25.6% | |
| Jan 11, 2022 | Clague Laura64 | Chief Financial Officer | Sell | 7,500 | $27.40 | $205,500.00 | -19.3% | +3.2% | -25.6% |